FDA Inspection 1136666 — Valescent Pharmaceuticals, Inc. dba VPI Compounding
The FDA completed an inspection of Valescent Pharmaceuticals, Inc. dba VPI Compounding on March 3, 2021 in Centennial, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 3, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Centennial, CO (United States)